Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Tissue expression, distribution, and regulation of PDE5

International Journal of Impotence Research volume 16, pages S8–S10 (2004)Cite this article

Abstract

Phosphodiesterase 5 (PDE5) has been identified in many species. The three isoforms, PDE5A1, PDE5A2, and PDE5A3, differ only in their N-terminal sequence. PDE5A1 and PDE5A2 are ubiquitous, but PDE5A3 is specific to smooth muscle. The initial three exons (A1–A3–A2) of PDE5A, located on chromosome 4q26, are alternative first exons encoding the isoform-specific sequences. The PDE5A promoter overlaps with the A1-specific exon, while the PDE5A2 promoter is located between the A3- and A2-specific exons. Both respond to cyclic guanosine monophosphate (cGMP) or cyclic adenosine monophosphate (cAMP) stimulation. The PDE5A2 promoter contains an Sp1-binding sequence critical for basal and cGMP/cAMP-inducible promoter activities. PDE5A is induced by adjacent sequences (enhancers) containing Sp1-binding sites. The potential role of PDE5A promoters in the tachyphylaxis effect of PDE5 inhibitors is currently being investigated. Preliminary data suggest that hypoxia might down-regulate PDE5A promoters, implying an involvement of PDE5 in stuttering priapism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kotera J et al. Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase. J Biol Chem 1998; 273: 26982–26990.

    Article  CAS  Google Scholar 

  2. Kotera J et al. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur J Biochem 1997; 249: 434–442.

    Article  CAS  Google Scholar 

  3. Lin CS, Lau A, Tu R, Lue TF . Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun 2000; 268: 628–635.

    Article  CAS  Google Scholar 

  4. Loughney K et al. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′5′-cyclic nucleotide phosphodiesterase. Gene 1998; 216: 139–147.

    Article  CAS  Google Scholar 

  5. Yanaka N et al. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene. Eur J Biochem 1998; 255: 391–399.

    Article  CAS  Google Scholar 

  6. Senzaki H et al. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J 2001; 15: 1718–1726.

    Article  CAS  Google Scholar 

  7. Wallis RM, Corbin JD, Francis SH, Ellis P . Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999; 83(5A): 3C–12C.

    Article  CAS  Google Scholar 

  8. Lin CS, Lau A, Tu R, Lue TF . Identification of three alternative first exons and an intronic promoter of human PDE5A gene. Biochem Biophys Res Commun 2000; 268: 596–602.

    Article  CAS  Google Scholar 

  9. Lin CS et al. Identification and regulation of human PDE5A gene promoter. Biochem Biophys Res Commun 2001; 280: 684–692.

    Article  CAS  Google Scholar 

  10. Lin CS et al. Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem Biophys Res Commun 2001; 280: 693–699.

    Article  CAS  Google Scholar 

  11. Lin G, Xin ZC, Lue TF, Lin CS . Up- and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003; 170: S15–S18.

    Article  Google Scholar 

  12. Danielson CF . The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002; 6: 24–31.

    Article  Google Scholar 

  13. Aboseif SR, Lue TF . Hemodynamics of penile erection. Urol Clin North Am 1988; 15: 1–7.

    CAS  PubMed  Google Scholar 

  14. Siegel JF, Rich MA, Brock WA . Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome. J Urol 1993; 150(5 Pt 1): 1480–1482.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of California, San Francisco, CA, USA

    C-S Lin

Authors
  1. C-S Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C-S Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, CS. Tissue expression, distribution, and regulation of PDE5. Int J Impot Res 16 (Suppl 1), S8–S10 (2004). https://doi.org/10.1038/sj.ijir.3901207

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901207

Keywords

This article is cited by

Search

Advanced search

Quick links